ENDOLOGIX INC /DE/ — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c4b47f8c-c19d-45e8-8620-329469f95b36/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2019 | $143.4M | 2019-01-01 – 2019-12-31 | evidence 0001013606-20-000026 |
| FY 2018 | $156.5M | 2018-01-01 – 2018-12-31 | evidence 0001013606-19-000059 |
| FY 2017 | $181.2M | 2017-01-01 – 2017-12-31 | evidence 0001013606-19-000059 |
| FY 2016 | $192.9M | 2016-01-01 – 2016-12-31 | evidence 0001013606-19-000059 |
| FY 2015 | $153.6M | 2015-01-01 – 2015-12-31 | evidence 0001013606-16-000208 |
| FY 2014 | $147.6M | 2014-01-01 – 2014-12-31 | evidence 0001013606-15-000016 |
| FY 2013 | $132.3M | 2013-01-01 – 2013-12-31 | evidence 0001013606-14-000012 |
| FY 2012 | $105.9M | 2012-01-01 – 2012-12-31 | evidence 0001013606-13-000019 |
| FY 2011 | $83.4M | 2011-01-01 – 2011-12-31 | evidence 0001013606-12-000008 |
| FY 2010 | $67.3M | 2010-01-01 – 2010-12-31 | evidence 0001013606-12-000008 |
| FY 2009 | $52.4M | 2009-01-01 – 2009-12-31 | evidence 0001013606-12-000008 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ENDOLOGIX INC /DE/ — all facts · Net Income · Operating Income